Emily Ferguson, NP
Nurse Practitioner · Jasper, INNPI 1194210575
Payments from drug & device makers
Across 362 payments — averaging $14.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$566
- AbbVie$563
- Novo Nordisk$562
- Lilly USA, LLC$551
- AstraZeneca$452
- Takeda Pharmaceuticals U.S.A., Inc.$302
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,086100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 60 | $566 |
| AbbVie | 48 | $563 |
| Novo Nordisk | 37 | $562 |
| Lilly USA, LLC | 34 | $551 |
| AstraZeneca | 23 | $452 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $302 |
| Axsome Therapeutics, Inc. | 21 | $278 |
| Boehringer Ingelheim | 15 | $241 |
| Otsuka America Pharmaceutical, Inc. | 19 | $220 |
| Amgen | 11 | $217 |
| Biohaven Pharmaceutical Holding Company Ltd. | 16 | $123 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $110 |
| Novartis | 5 | $91 |
| Biohaven Pharmaceuticals, Inc. | 5 | $87 |
| Abbott | 4 | $85 |
| Exact Sciences | 5 | $84 |
| Corium, LLC | 6 | $80 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $64 |
| Sumitomo Pharma America, Inc. | 3 | $49 |
| E.r. Squibb & Sons, L.L.C. | 3 | $37 |
| Bayer | 2 | $37 |
| Sunovion Pharmaceuticals Inc. | 2 | $36 |
| Amneal Pharmaceuticals LLC | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| GSK | 2 | $29 |
| Biogen | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Scynexis, Inc. | 1 | $21 |
| Merck | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Eisai Inc. | 1 | $13 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $12 |
How this compares
$5,093 in reported general payments places this provider in the 90th percentile of 2,724 nurse practitioner providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 77 | $91,240 |
| EliquisApixaban | 31 | $37,064 |
| FarxigaDapagliflozin Propanediol | 29 | $34,943 |
| JardianceEmpagliflozin | 33 | $30,420 |
| MounjaroTirzepatide | 28 | $29,076 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 30 | $28,456 |
| TrulicityDulaglutide | 12 | $11,491 |
| JanuviaSitagliptin Phosphate | 13 | $9,769 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $8,401 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $4,928 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $3,937 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $3,080 |
| Varenicline Tartrate | 12 | $3,022 |
| Eszopiclone | 12 | $2,662 |
| Esomeprazole Magnesium | 15 | $2,040 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $562 | $91,24077 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $452 | $66,47872 claims |
| Lilly USA, LLCMounjaro, Trulicity, Insulin Lispro | $551 | $41,08651 claims |
| PfizerEliquis | $566 | $37,06431 claims |
| Boehringer IngelheimJardiance | $241 | $30,42033 claims |
| MerckJanuvia | $17 | $9,76913 claims |
| GSKTrelegy Ellipta | $29 | $8,40113 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $34 | $1,028141 claims |
| Sanofi-aventis U.S. LLCLantus | $15 | $1,02317 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,724 nurse practitioner providers in Indiana.
Other nurse practitioner in Jasper
- Dixie StilesJasper$9K
- Kristi OrbaughIndianapolis$1.3M
- Kimberly EadsPlainfield$302K
- Sean GoddardFort Wayne$180K
- Kacy RogersIndianapolis$77K
- Kristine TaylorFort Wayne$69K
- Brittany SavageIndianapolis$51K
- Monica HaugerTrafalgar$47K
- Rhonda HettingerClarksville$38K
- Jennifer MaahsIndianapolis$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.